Visualitza per autor "Pérez García, José"
Ara mostrant els elements 1-1 d 1
-
Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial
Gavilá Gregori, Joaquín; Antunes de Melo Oliveira, Ana Mafalda; Pascual, Tomás; Pérez García, José; Gonzàlez, Xavier; Canes, Jordi (BMC, 2019-01-09)